Dendreon Raising Cash
Updated from 4:54 p.m. EDT
Dendreon (DNDN) is raising money.
The Seattle-based drug company is expected to sell 10 million shares in an overnight financing deal Thursday, according to a prospectus emailed to potential investors by Deutsche Bank Securities, which is handling the deal.
No firm information on pricing was provided, but multiple sources said the price range being considered is $18.70 to $19.20 a share, a slight discount to Dendreon's Thursday's closing price of $19.76. At the midpoint of the pricing range, gross proceeds would total $189.5 million.Dendreon is also offering an over-allotment of 1.5 million shares, so the total money raised could be higher. Dendreon's decision to raise money Thursday night comes a week after the company presented survival data for its prostate cancer vaccine Provenge at a medical meeting in Chicago.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV